About AbbVie

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

What We Do

As a new biopharmaceutical company, AbbVie combines the expertise of a recognised pharmaceutical company with the focus and innovative spirit of a biotech. Through a targeted,patient-centric approach to research and development, AbbVie accelerates new scientific discoveries to address some of the most complex diseases in the world, while our services and partnerships help us create greater access and outcomes for the health of all Australians.

We focus on discovering, developing, and delivering medicines in therapeutic areas where we have proven expertise and where we can have an impact. These areas include: Immunology, Oncology, Virology and Neuroscience

Click here to view the AbbVie Corporate Brochure.

Our History

AbbVie may have been founded in 2013, but our roots run deep and our local heritage in Australia reaches back more than 80 years. In 2013, we became a separate company from Abbott, though we share a common legacy and strong prospects for future success.

Our name represents our connection to the past and the future. When we became our own company, AbbVie formed a new kind of enterprise—a biopharmaceutical company. We blend the stability, global scale, resources and commercial capabilities of a pharmaceutical company with the focus and culture of a biotech.

Today, our 29,000 employees around the world focus on delivering transformational medicines and therapies that offer significant patient benefits.